Merck Scores A First With Keytruda Under Australia's Provisional Pathway
Executive Summary
The Therapeutic Goods Administration has provisionally approved new uses of the anticancer medicine based on early clinical data.
You may also be interested in...
Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway
Australia gets the ball rolling on its new pathway for provisional approval of innovative prescription medicines.
Eligibility Decisions Near For Australia’s New Provisional Pathway
The first registration of a medicine under Australia’s new provisional approval pathway could take place at the end of this year, according to plans by the Therapeutic Goods Administration.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.